[ON CANCER THERAPY WITH PODOPHYLLIN DERIVATIVES. PRELIMINARY EXPERIENCES IN THE CYTOSTATIC TREATMENT OF MALIGNANT GENITAL TUMORS WITH SP-I AND SP-G SANDOZ].
D000970:Antineoplastic Agents; D002822:Choriocarcinoma; D054697:Cytostatic Agents; D005260:Female; D006801:Humans; D011033:Podophyllin; D011035:Podophyllum; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms; D014625:Vaginal Neoplasms
D000970:Antineoplastic Agents; D054697:Cytostatic Agents; D011033:Podophyllin
ANTINEOPLASTIC AGENTS; CERVIX NEOPLASMS; CHORIOCARCINOMA; PODOPHYLLUM; UTERINE NEOPLASMS; VAGINAL NEOPLASMS
ZUR KREBSTHERAPIE MIT PODOPHYLLIN-DERIVATEN. VORLAEUFIGE ERFAHRUNGEN BEI DER ZYTOSTATISCHEN BEHANDLUNG MALIGNER GENITALTUMOREN MIT SP-I UND SP-G SANDOZ.